Pneumo23

Name: Pneumo23 in Systemic-Onset Juvenile Idiopathic Arthritis
Creator: Floatz
License: https://terminal.floatz.ai/terms

Systemic-Onset Juvenile Idiopathic Arthritis

Institut National de la Santé Et de la Recherche Médicale, FrancePhase 2/3Dormant

61/ 100

Provisional rating · Methodology v0.2

Rating breakdown

6 Active assets in the Systemic-Onset Juvenile Idiopathic Arthritis cohort.

Asset / Sponsor	Phase	Rating
IMMUNOGLOBULIN G1, ANTI-(HUMAN INTERLEUKIN 1.BETA.) (HUMAN CLONE ACZ885 HEAVY CHAIN V REGION) Novartis Pharmaceuticals	Phase 3	BB
Anakinra Institut National de la Santé Et de la Recherche Médicale, France	Phase 2/3	B
Thiotepa Paul Szabolcs	Phase 2	CCC
IMMUNOGLOBULIN G1 (HUMAN-RAT MONOCLONAL CAMPATH-1H .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD52), DISULFIDE WITH HUMAN-RAT MONOCLONAL CAMPATH-1H LIGHT CHAIN, DIMER Paul Szabolcs	Phase 2	CCC
Fludarabine Paul Szabolcs	Phase 2	CCC
Evomela Paul Szabolcs	Phase 2	CCC
Hydroxyurea Paul Szabolcs	Phase 2	CCC

Order a full diligence report on this asset.

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.